U.S. Stock News

Wondering whether Amprius Technologies at US$21.40 is still worth your attention after a rapid run up, or if the price has already moved ahead of the fundamentals? The stock has returned 8.7% over the last week, 33.8% over the last month, 144.9% year to date, and a very large 1 year return of 822.4%, which puts recent trading firmly on most investors' radar. Recent coverage has focused on Amprius Technologies as interest in battery and electrification related companies has increased, with...

First Bancorp recently reported first-quarter 2026 results, with net interest income rising to US$107.12 million and net income to US$46.66 million, while also disclosing US$1.40 million in net charge-offs for the period. The bank also strengthened its governance and industry expertise by adding alternative-investments specialist Kate Nevin and higher-education leader Peter Hans to its Board of Directors. With earnings growth and expanded board expertise in focus, we’ll now examine how these...

Integer Holdings (NYSE:ITGR) has begun a comprehensive review of its business and capital structure. The Board is assessing options that may include a sale, merger, or other business combination. The review follows heightened external interest in the company and involves financial and legal advisors. The process is focused on assessing ways to maximize value for existing shareholders. Integer Holdings, traded on the NYSE under the ticker ITGR, operates in the medical technology space,...

Tronox Holdings plc recently confirmed a quarterly dividend of US$0.0500 per share payable on July 8, 2026, with both the ex-dividend and record dates set in the past on May 11, 2026. Around the same time, Truist downgraded Tronox to Sell, highlighting concerns about cost pressures and near-term earnings guidance despite the dividend affirmation. With Truist’s downgrade foregrounding near-term earnings pressures, we’ll now examine how this development reshapes Tronox’s existing investment...

Heartland Express, Inc. previously reported first-quarter 2026 results showing sales of US$176.26 million versus US$219.42 million a year earlier, with net loss narrowing to US$4.82 million and no share repurchases during the period under its existing buyback programs. Alongside the smaller loss, investors also learned that long-time executive David P. Millis retired as President of Millis Transfer while remaining on Heartland’s board, a leadership shift that may influence how integration...

Stock performance snapshot and why FTI Consulting is on investors’ radar FTI Consulting (FCN) has drawn investor attention after recent price moves, with the stock closing at US$166.95. Returns over the past week, month and past 3 months have all been negative. See our latest analysis for FTI Consulting. The recent pullback, including a 1-day share price return of negative 0.65% and a 30-day share price return of negative 8.93%, sits against a 5-year total shareholder return of 17.65%. This...

Supernus Pharmaceuticals (SUPN) is back in focus after reporting first quarter 2026 results that topped Wall Street earnings and revenue expectations, with Qelbree, GOCOVRI, ZURZUVAE, and ONAPGO playing key roles. See our latest analysis for Supernus Pharmaceuticals. Supernus Pharmaceuticals’ share price has been broadly steady in recent months, with a 2.7% 1 month share price decline and a roughly flat 90 day move. However, a 59.0% 1 year total shareholder return points to strong longer term...

Context for Ross Stores stock Ross Stores (ROST) has drawn investor attention recently as its stock screens show a market value of about US$72.8b and reported annual revenue of US$22.8b with net income of US$2.1b. See our latest analysis for Ross Stores. The share price has gained clear traction recently, with a 20.16% 90 day share price return and 24.45% year to date, while the 1 year total shareholder return of 62.2% points to strong, sustained momentum. If Ross Stores strong run has you...

Why Onto Innovation Is Drawing Fresh Attention Recent trading in Onto Innovation (ONTO) has turned heads, with the stock showing strong gains over the past month and past 3 months, prompting investors to reassess its semiconductor equipment exposure. See our latest analysis for Onto Innovation. That recent strength is part of a longer run, with a 30 day share price return of 41.51% and a 1 year total shareholder return of 149.14%, pointing to strong momentum rather than a short lived...

Event driven snapshot of Acadia Healthcare Company (ACHC) Acadia Healthcare Company (ACHC) shares have been volatile recently, with a 9% decline over the past week offset by gains of about 5% over the month and roughly 86% in the past 3 months. See our latest analysis for Acadia Healthcare Company. At a share price of $25.27, Acadia Healthcare Company's recent share price return shows sharp short term swings but strong recent momentum, with a 5.47% 30 day gain and 86.49% 90 day gain. This...

If you are wondering whether Keysight Technologies at around US$355.93 is a bargain or already pricing in a lot of optimism, the starting point is to understand what the current valuation is actually implying. The stock has shown strong recent momentum, with returns of 7.1% over 7 days, 22.2% over 30 days, 72.3% year to date, 142.9% over 1 year, 148.9% over 3 years and 156.2% over 5 years. This naturally raises questions about how much upside or risk is now baked into the price. Recent...

CleanSpark (NasdaqCM:CLSK) is accelerating a shift from pure Bitcoin mining toward hosting AI and high performance computing data centers. The company is in advanced talks with a potential investment grade hyperscaler tenant for direct data center capacity. New greenfield AI data center construction is underway in Georgia, backed by CleanSpark’s existing power portfolio. Management is publicly addressing concerns around data center power and water usage as part of this transition. For you...

Amgen (NasdaqGS:AMGN) has been selected by the FDA as one of only two companies to run proof of concept trials under the new real time clinical trials initiative. The program is designed to enable continuous clinical development with real time data sharing between companies and the FDA. The collaboration focuses on reshaping how trials are designed, monitored, and adapted during the development of new therapies. Amgen is a large biotechnology company with a broad portfolio of therapies and...

In early May 2026, Entergy Corporation filed a follow-on equity offering of US$2.18 billion in common stock, shortly after reporting first-quarter 2026 revenue of US$3,187.63 million and net income of US$384.92 million. An interesting aspect is that Entergy is seeking to raise a very large amount of new equity just days after posting higher year-on-year sales and net income, which may influence how investors view its capital needs and future projects. We’ll now examine how this sizable...

Investors may be wondering if Prudential Financial at around US$100 a share still offers value, or if most of the opportunity has already been priced in. The stock last closed at US$100.27, with returns of 3.5% over the past week, 2.8% over the past month, 3.7% over the last year and 43.0% over three years. Year to date it is down 11.9% and up 21.6% over five years. Recent headlines have focused on Prudential Financial in the context of broader insurance sector sentiment and changing...

Dentsply Sirona has reported Q1 2026 results showing essentially flat sales of US$880 million year on year but a swing from a US$20 million net profit to a US$10 million net loss, while also advancing its Return-to-Growth plan. At the same time, the company launched Smart View – Detect, the first FDA-cleared AI-enabled diagnostic aid for PARL detection in CBCT scans, and expanded its U.S. digital dentistry reach through an enhanced distribution agreement with Atlanta Dental Supply. We’ll now...

FDA approves Jakafi XR extended-release tablets for myelofibrosis, polycythemia vera and graft-versus-host disease. Jakafi XR offers a once-daily dosing option that differs from existing formulations of ruxolitinib. The approval expands Incyte's Jakafi franchise and broadens its treatment toolkit across several serious blood and immune conditions. For investors watching NasdaqGS:INCY, this latest approval sits at the heart of the company’s core focus in hematology and oncology. Jakafi has...

Mattel has completed the acquisition of mobile game studio Mattel163, taking full control of its digital gaming business. The company is rolling out the new Mattel Brick Shop, a construction toy concept positioned to compete more directly with LEGO. Mattel is also deepening its entertainment efforts, tying its brands more closely to film and content projects. NasdaqGS:MAT is trading at $14.72, with the stock down 26.5% year to date and 30.3% over five years. In this context, the decision to...

In recent weeks, LegalZoom.com drew fresh attention by offering free trademark legal support to Taylor Swift and other public figures to counter AI-driven impersonations, while investors also looked ahead to its upcoming earnings release. This high-profile move highlights how LegalZoom is positioning its brand at the center of emerging AI-related identity and intellectual property concerns. We’ll now examine how LegalZoom’s high-profile AI impersonation support offer could influence its...

In recent weeks, Critical Metals Corp. secured Greenland government approval to acquire a 70% stake in 60° North Greenland ApS and closed the transfer that lifted its ownership of the Tanbreez Mining Greenland rare earth project to 92.5%, while progressing plans to acquire the remaining 7.5% via European Lithium. These moves, alongside advancing pilot plant work at Tanbreez and building a Romanian mine-to-magnet JV focused on NATO and EU supply chains, materially deepen Critical Metals’...

MSA Safety (MSA) has just opened Q1 2026 earnings season with a run of solid headline figures, capped by Q4 2025 revenue of US$510.9 million and basic EPS of US$2.22. Over recent quarters the company has seen revenue move from US$499.7 million in Q4 2024 to US$421.3 million in Q1 2025 and then back to US$510.9 million in Q4 2025, while quarterly EPS ranged between roughly US$1.51 and US$2.23, setting up a results story where margins and profit quality are front and center for investors. See...

Wondering if Allison Transmission Holdings at around US$127 per share is still good value, or if most of the easy upside is already behind it. The stock has seen a 2% decline over the last 7 days, but is up 8.8% over 30 days, 28.7% year to date, 32.7% over 1 year and more than 7x over 5 years. This naturally raises questions about what is now priced in. Recent coverage has focused on Allison Transmission Holdings as a long term compounder for investors who held through the last several...

Event overview and why it matters for Westamerica Bancorporation (WABC) Westamerica Bancorporation (WABC) has expanded its share repurchase authorization to 4,000,000 shares and lifted its quarterly dividend to $0.48, indicating a focus on returning cash to shareholders. See our latest analysis for Westamerica Bancorporation. At a share price of $54.75, Westamerica Bancorporation has a 30 day share price return of 5.63% and a year to date share price return of 14.47%, alongside a 3 year total...

If you have been wondering whether PG&E at US$16.33 is priced attractively or not, the key question is how that share price lines up against the company’s underlying value. The stock has been relatively steady over the last year with a 0.4% return year to date and a 3.3% decline over 12 months. Over the last 30 days it declined 8.1%, following a modest 0.4% gain over the past week. Recent news around PG&E has continued to focus on its role as a major California electric utility, including...